Amicus Therapeutics Inc (NASDAQ:FOLD)

15.24
Delayed Data
As of Feb 23
 +0.16 / +1.06%
Today’s Change
5.87
Today|||52-Week Range
17.40
+5.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues363.0K1.2M0.005.0M
 
 
 
 
Cost of Goods Sold----0.00833.0K
 
 
Depreciation And Amortization1.7M1.5M1.8M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income-----1.8M883.0K
 
 
 
General Expenses60.3M68.3M121.1M169.4M
 
 
 
 
 
Research And Development41.9M47.6M76.9M98.3M
 
 
 
 
 
Total Operating Expenses62.1M69.9M122.9M173.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.7M-68.7M-122.9M-168.6M
 
 
 
 
 
Extraordinary Credit908.0K63.0K0.000.00
 
 
 
Extraordinary Charge-2.5M-100.0K-8.4M-26.9M
 
 
 
 
 
Interest Expense On Debt46.0K1.5M1.6M5.4M
 
 
 
 
 
Other Expenses0.00-77.0K-80.0K-4.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-63.1M-70.0M-132.1M-203.8M
 
 
 
 
 
Income Taxes-3.5M-1.1M0.00-3.7M
 
 
 
 
Net Income-59.6M-68.9M-132.1M-200.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.3M74.4M109.9M134.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.3M74.4M109.9M134.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$0.93-$1.20-$1.49
 
 
 
 
 
EPS Diluted-$1.16-$0.93-$1.20-$1.49